Interleukin-1β augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus

F. Shintani, S. Kanba, T. Nakaki, M. Nibuya, N. Kinoshita, E. Suzuki, G. Yagi, R. Kato, M. Asai

Research output: Contribution to journalArticlepeer-review

278 Citations (Scopus)

Abstract

We investigated the effects of interleukin-1β (IL-1β), administered directly into the rat anterior hypothalamus (AHY), on monoamine release in the same region by using a brain microdialysis technique and an HPLC- electrochemical detection system. First, to study the local effects of IL- 1β, we used a microdialysis probe equipped with a microinjection tube for administering IL-1β in the same region into which the probe had been inserted. IL-1β (1 ng) injected directly into the AHY elicited release of norepinephrine (NE), dopamine (DA), and 5-HT, as well as increases in their metabolites, 4-hydroxy-3-methoxyphenylglycol, 3,4-dihydroxy-phenylacetic acid, 4-hydroxy-3-methoxyphenylacetic acid, and 5-hydroxyindole-3-acetic acid, in the AHY. Vehicle alone exerted no effect on monoamine release. Although the elevated levels of NE and DA persisted for more than 6 hr after injection of IL-1β, the elevated levels of 5-HT were transient. Second, in order to investigate whether this effect of IL-1β is a direct action in the AHY, we performed in vitro experiments using hypothalamus slices. IL-1β (0.1 and 1 nM) increased the levels of each monoamine released from hypothalamic slices in a dose-dependent manner. These findings suggest that IL-1β acts directly on the hypothalamus to induce release of NE, DA, and 5-HT. Third, the roles of prostaglandins (PGs) in NE release in the AHY elicited by direct injection of IL-1β were examined. Indomethacin (INDO; 5 mg/kg) was administered intraperitoneally, and then 1 hr later, IL-1β (1 ng) was injected directly into the AHY through the microinjection tube. IL-1β was still capable of increasing NE release, although the INDO pretreatment had decreased 6-ketoprostaglandin F1α levels in the rat hypothalamus. Fourth, to exclude the possibility that corticotropin-releasing hormone (CRH) is involved in NE release by IL-1β, rats were pretreated with dexamethasone (DXM; 0.3 mg/kg), and then NE release in the AHY elicited by IL-1β was measured. IL-1β was still capable of inducing NE release, although the DXM pretreatment had decreased blood adrenocorticotropic hormone levels. These findings suggest that IL-1β acts directly on the AHY to augment the release of NE without PG involvement or elevation of CRH levels.

Original languageEnglish
Pages (from-to)3574-3581
Number of pages8
JournalJournal of Neuroscience
Volume13
Issue number8
DOIs
Publication statusPublished - 1993

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Interleukin-1β augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus'. Together they form a unique fingerprint.

Cite this